These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 19270352)

  • 1. [Association of cathepsin L with coronary heart disease and its risk factors].
    Wang J; Liu Y; Li X; Peng D; Tan Z; Liu H; Qin Y; Xue Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Feb; 34(2):130-4. PubMed ID: 19270352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
    Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on C-reactive protein and the risk factors of traditional coronary heart disease].
    Guo ZR; Hu XS; Chen FM; Wu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1064-8. PubMed ID: 18396656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: the PRIME Study.
    Bataille V; Perret B; Troughton J; Amouyel P; Arveiler D; Woodside J; Dallongeville J; Haas B; Bingham A; Ducimetière P; Ferrières J
    Int J Cardiol; 2006 Apr; 108(2):189-96. PubMed ID: 15925416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of the new gaseous transmitter H2S in patients with coronary heart disease].
    Jiang HL; Wu HC; Li ZL; Geng B; Tang CS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):951-4. PubMed ID: 16109547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cathepsin L and its related pro/antiangiogenic factors play useful roles in predicting rich coronary collaterals in patients with coronary heart disease.
    Zhang J; Wang P; Huang YB; Li J; Zhu J; Luo X; Shi HM; Li Y
    J Int Med Res; 2010; 38(4):1389-403. PubMed ID: 20926012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of risk factors for coronary heart disease in urban Indian middle-aged males.
    Jain P; Jain P; Bhandari S; Siddhu A
    Indian Heart J; 2008; 60(3):233-40. PubMed ID: 19240313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the contents of serum HDL subclasses and the extent of coronary stenosis in coronary heart disease patients].
    Xu YX; Fu MD; Xu YH; Yang LC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):500-2. PubMed ID: 15291110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
    Schwedhelm E; Bartling A; Lenzen H; Tsikas D; Maas R; Brümmer J; Gutzki FM; Berger J; Frölich JC; Böger RH
    Circulation; 2004 Feb; 109(7):843-8. PubMed ID: 14757688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease].
    Wang CH; Zhou X; Zhou GD; Han DF; Zheng F
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):554-8. PubMed ID: 15144588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity, coronary heart disease, and inflammatory response.
    Rothenbacher D; Hoffmeister A; Brenner H; Koenig W
    Arch Intern Med; 2003 May; 163(10):1200-5. PubMed ID: 12767957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for coronary heart disease in a population with a high prevalence of obesity and diabetes: a case-control study of the Polynesian population of Western Samoa.
    Wahi S; Gatzka CD; Sherrard B; Simpson H; Collins V; Dowse G; Zimmet P; Jennings G; Dart AM
    J Cardiovasc Risk; 1997 Jun; 4(3):173-8. PubMed ID: 9475671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between coronary heart disease and cancers of the breast, prostate, and colon.
    Neugut AI; Rosenberg DJ; Ahsan H; Jacobson JS; Wahid N; Hagan M; Rahman MI; Khan ZR; Chen L; Pablos-Mendez A; Shea S
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):869-73. PubMed ID: 9796631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
    Rothenbacher D; Brenner H; März W; Koenig W
    Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
    Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
    Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly].
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):827-31. PubMed ID: 12895332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
    Keavney B; Danesh J; Parish S; Palmer A; Clark S; Youngman L; Delépine M; Lathrop M; Peto R; Collins R
    Int J Epidemiol; 2006 Aug; 35(4):935-43. PubMed ID: 16870675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.